文献速递慢阻肺睡眠呼吸障碍

COPD患者睡眠质量受损与急性加重相关:CanCOLD队列研究

Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study.
PubMed 文献 · Chest · 2019-05-28

该研究基于加拿大COPD队列(CanCOLD),纳入480例完成18个月随访的COPD患者,用匹兹堡睡眠质量指数(PSQI)评估基线睡眠质量。结果显示基线PSQI评分越高,症状型及事件型急性加重风险越高,且睡眠质量差者症状型急性加重无生存期更短,关联主要见于未确诊COPD者。

要点

  • 基线PSQI评分越高,COPD急性加重风险越高
  • 睡眠质量差的COPD患者症状型急性加重出现更早
  • 关联主要见于未确诊COPD人群,应关注其睡眠筛查

核心结论

  • 基线PSQI评分较高与18个月前瞻性随访期间COPD急性加重风险增加相关。

研究设计与样本

  • 基于加拿大COPD队列(CanCOLD)的人群样本研究,纳入完成18个月随访的480例COPD患者,用PSQI及三因子分析评估睡眠质量,用负二项回归评估PSQI与急性加重率的关联。

主要发现

  • 后续发生症状型急性加重者基线PSQI中位数高于未发生者(6.0[四分位距3.0-8.0]比5.0[四分位距2.0-7.0],P=.01)。
  • 症状型急性加重者基线PSQI>5的比例更高(50.3%比37.3%,P=.01)。
  • PSQI评分越高,症状型急性加重风险越高(校正率比1.09,95%CI 1.01-1.18,P=.02),事件型急性加重风险亦升高(校正率比1.10,95%CI 1.00-1.21,P=.048)。
  • 关联主要见于未确诊COPD者,与因子3(睡眠紊乱与日间功能障碍)关联最强。
  • 睡眠质量差者至症状型急性加重时间更短(校正风险比1.49,95%CI 1.09-2.03)。

关键数值与推荐

  • PSQI评分>5定义为基线睡眠质量差,480例中203例符合。
  • 随访期间185例发生一次或以上急性加重。
  • 症状型急性加重定义为呼吸困难或痰量变化持续≥48小时;事件型为症状加用药或非计划就诊。

临床怎么用

  • 对COPD患者可考虑用PSQI评估睡眠质量,睡眠质量差者或需加强急性加重监测与随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COPD increases susceptibility to sleep disturbances, which may in turn predispose to increased respiratory symptoms. The objective of this study was to evaluate, in a population-based sample, the relationship between subjective sleep quality and risk of COPD exacerbations. METHODS: Data were obtained from the Canadian Cohort Obstructive Lung Disease (CanCOLD) study. Participants with COPD who had completed 18 months of follow-up were included. Sleep quality was measured with the Pittsburgh Sleep Quality Index (PSQI) and a three-factor analysis. Symptom-based (dyspnea or sputum change ≥ 48 h) and event-based (symptoms plus medication or unscheduled health services use) exacerbations were assessed. Association of PSQI with exacerbation rate was assessed by using negative binomial regression. Exacerbation-free survival was also assessed. RESULTS: A total of 480 participants with COPD were studied, including 185 with one or more exacerbations during follow-up and 203 with poor baseline sleep quality (PSQI score > 5). Participants with subsequent symptom-based exacerbations had higher median baseline PSQI scores than those without (6.0 [interquartile range, 3.0-8.0] vs 5.0 [interquartile range, 2.0-7.0]; P = .01), and they were more likely to have baseline PSQI scores > 5 (50.3% vs 37.3%; P = .01). Higher PSQI scores were associated with increased symptom-based exacerbation risk (adjusted rate ratio, 1.09; 95% CI, 1.01-1.18; P = .02) and event-based exacerbation risk (adjusted rate ratio, 1.10; 95% CI, 1.00-1.21; P = .048). The association occurred mainly in those with undiagnosed COPD. Strongest associations were with Factor 3 (sleep disturbances and daytime dysfunction). Time to symptom-based exacerbation was shorter in participants with poor sleep quality (adjusted hazard ratio, 1.49; 95% CI, 1.09-2.03). CONCLUSIONS: Higher baseline PSQI scores were associated with increased risk of COPD exacerbation over 18 months' prospective follow-up.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Shorofsky M, Bourbeau J, Kimoff J, et al. Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study. Chest. 2019. PMID: 31150638. doi:10.1016/j.chest.2019.04.132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。